Hasil Pencarian - Kiyotaka Yoh, MD
- Menampilkan 1 - 2 hasil dari 2
-
1
Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immuno... oleh Takehito Shukuya, MD, PhD, Kazuya Takamochi, MD, PhD, Hiroyuki Sakurai, MD, PhD, Kiyotaka Yoh, MD, Tomoyuki Hishida, MD, PhD, Masahiro Tsuboi, MD, PhD, Yasushi Goto, MD, PhD, Yujin Kudo, MD, PhD, Yasuhisa Ohde, MD, PhD, Sakae Okumura, MD, Masataka Taguri, PhD, Hideo Kunitoh, MD
Diterbitkan 2022-05-01Dapatkan teks lengkap
Artikel -
2
The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study) oleh Kageaki Watanabe, MD, Yukio Hosomi, MD, PhD, Katsuhiko Naoki, MD, PhD, Yoshiro Nakahara, MD, PhD, Yoko Tsukita, MD, PhD, Hirotaka Matsumoto, MD, PhD, Kiyotaka Yoh, MD, Yasuhito Fujisaka, MD, PhD, Satoshi Takahashi, MD, PhD, Saori Takata, MD, PhD, Kazuhiro Usui, MD, PhD, Kazuma Kishi, MD, PhD, Go Naka, MD, PhD, Shu Tamano, MSS, Kohei Uemura, PhD, Hideo Kunitoh, MD, PhD
Diterbitkan 2024-11-01Dapatkan teks lengkap
Artikel